Translational approaches: From fatty liver to non-alcoholic steatohepatitis-中国Betway体育网页登陆

摘要 Overthepastfewdecades,non-alcoholicfattyliverdisease(NAFLD)hasbecomeone,ifnotthemostcommon,causeofchronicliverdiseaseaffectingbothadultsandchildren.Theincreasingnumberofcasesatanearlyageisthemostworryingaspectofthispathology,sinceitprovidesmoretimeforitsevolution.Thespectrumofthisdiseaserangesfromliversteatosistosteatohepatitis,fibrosisandinsomecases,hepatocellularcarcinoma.NAFLDmaynotalwaysbeconsideredabenigndiseaseandhepatologistsmustbecautiousinthepresenceoffattyliver.Thisshouldprompttheuseoftheavailableexperimentalmodelstounderstandbetterthepathogenesisandtodeveloparationaltreatmentofadiseasethatisdangerouslyincreasing.Inspiteofthegrowingefforts,thepathogenesisofNAFLDisstillpoorlyunderstood.InthepresentarticlewereviewthemostrelevanthypothesesandevidencethataccountfortheprogressionofNAFLDtonon-alcoholicsteatohepatitis(NASH)andfibrosis.TheavailableinvitroandinvivoexperimentalmodelsofNASHarediscussedandrevisedintermsoftheirvalidityintranslationalstudies.Thesestudiesmustbeaimedatthediscoveryofthestillunknowntriggersormediatorsthatinducetheprogressionofhepaticinflammation,apoptosisandfibrosis.

1Guanlin Li,Xinrong Zhang,Huapeng Lin,Lilian Yan Liang,Grace Lai-Hung Wong,Vincent Wai-Sun Wong.Non-invasive tests of non-alcoholic fatty liver disease.医药卫生,2022-12.
2Kaitlyn G. Jackson,Grayson W. Way,Huiping Zhou.Bile acids and sphingolipids in non-alcoholic fatty liver disease.医药卫生,2022-12.
3S. Rios Rafael,I Zheng Kenneth,Targher Giovanni,Byrne Christopher D.,Zheng Ming-Hua.Non-invasive fibrosis assessment in non-alcoholic fatty liver disease.医药卫生,2020-11.
4Xiaoli Pan,Yanqiao Zhang.Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease.医药卫生,2022-12.
5Qi Xiao-Yan,Li Jiao-Yang,Wang Ya-Di,Zeng Yan-Wen,Liao Zhe-Zhen,Ran Li,Yang Jing,Wen Ge-Bo,Liu Jiang-Hua,Xiao Xin-Hua.Association of serum zinc-α2-glycoprotein with non-alcoholic fatty liver disease.医药卫生,2020-08.
6Yizhi Zhang,Yu Chen.Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.医药卫生,2022-12.
7Xin Tong,Yu Song,Shengxia Yin,Jian Wang,Rui Huang,Chao Wu,Junping Shi,Jie Li.Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease.医药卫生,2022-12.
8Jiaye Liu,Ye Tian,Xia Fu,Chunyang Mu,Menglin Yao,Yinyun Ni,Yong Liu,Zhihui Li.Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis.医药卫生,2022-12.
9Andrea Sanchez-Pareja;Sophie Clément;Marion Peyrou;Laurent Spahr;Francesco Negro;Laura Rubbia-Brandt;Michelangelo Foti.phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.消化系统,2016-12.
10Zheng Kenneth I.,Fan Jian-Gao,Shi Jun-Ping,Wong Vincent Wai-Sun,Eslam Mohammed,George Jacob,Zheng Ming-Hua.From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.医药卫生,2020-10.

Translational approaches: From fatty liver to non-alcoholic steatohepatitis

来源期刊

相关推荐

同分类资源更多

相关关键词